Archives

  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • Leptin (116-130), amide, mouse: Precision for Energy Homeost

    2026-05-27

    Leptin (116-130), amide, mouse: Precision Tools for Energy Homeostasis and Metabolic Research

    Principle Overview: Leveraging an Adipocyte-Derived Hormone Fragment

    Leptin (116-130), amide, mouse is a bioactive peptide fragment corresponding to amino acids 116-130 of native mouse leptin, a central adipocyte-derived hormone. This sequence (Ser-Cys-Ser-Leu-Pro-Gln-Thr-Ser-Gly-Leu-Gln-Lys-Pro-Glu-Ser-NH2) retains the key receptor-interaction motifs responsible for modulating food intake and energy homeostasis regulation, while offering enhanced experimental tractability. By mimicking the metabolic and pleiotropic effects of full-length leptin—yet with greater control over dose, solubility, and specificity—researchers can dissect leptin signaling pathways implicated in obesity, diabetes, and leptin resistance with high reproducibility (product details).

    Experimental Workflow: Stepwise Protocol and Enhancements

    The versatility of Leptin (116-130), amide, mouse, supplied as a stable solid, enables a range of in vitro and in vivo applications. Its robust solubility in DMSO (≥156 mg/mL) and water (≥24.15 mg/mL) further streamlines assay setup. Below is a step-by-step workflow to maximize reproducibility and biological relevance in metabolic and signaling studies.

    Protocol Parameters

    • Stock solution preparation: Dissolve at 2 mg/mL in sterile water or DMSO; vortex until fully solubilized. Prepare fresh prior to each experiment to avoid degradation.
    • Cell culture treatments: Use working concentrations ranging from 0.1 to 10 μM for adipocyte, hypothalamic neuron, or immune cell assays; typical incubation time is 24-48 hours at 37°C with 5% CO2.
    • Animal studies: Administer 0.2–1 mg/kg via intraperitoneal injection daily for 7–14 days to model effects on body weight, food intake, or metabolic endpoints in C57BL/6 mice.
    • Storage: Store the lyophilized peptide desiccated at -20°C. Avoid repeated freeze-thaw cycles; do not store reconstituted solutions long-term.

    Key Innovation from the Reference Study

    The reference study by Zhou et al. provides a critical mechanistic bridge between metabolic signaling and inflammation in murine models. It demonstrates that berberine modulates SIRT6-AMPK pathway activation to inhibit the NLRP3 inflammasome, reducing atrial fibrosis and susceptibility to arrhythmia. This insight is pivotal for leptin fragment research, as the SIRT6-AMPK axis is also a key node in leptin-mediated energy homeostasis and inflammation. By employing Leptin (116-130), amide, mouse, researchers can precisely interrogate how leptin signaling intersects with SIRT6-AMPK-dependent pathways, refining models of obesity, diabetes, and cardiac remodeling.

    Advanced Applications and Comparative Advantages

    Unlike full-length leptin, Leptin (116-130), amide, mouse offers several unique advantages for metabolic, cardiovascular, and immuno-metabolic research:

    • Modeling leptin resistance and deficiency: The peptide fragment allows controlled titration to simulate hypo- or hyper-leptinemic states, enabling mechanistic dissection of obesity and diabetes pathogenesis.
    • Decoupling pleiotropic effects: By focusing on a critical signaling domain, researchers can parse out energy regulation versus immune or vascular actions, as highlighted in this detailed workflow guide, which complements the current protocol by offering troubleshooting for leptin signaling specificity.
    • Enhanced solubility and storage: The high solubility in water and DMSO facilitates high-concentration dosing and multi-assay compatibility, as underscored in both previous guides and the product documentation.
    • Translational relevance: Studies such as "Leptin (116-130), amide, mouse: Precision Tools for Metabolic Research" extend these findings, illustrating how this peptide bridges cell-based assays and in vivo metabolic phenotyping, supporting robust translational pipelines for preclinical drug validation.

    Troubleshooting & Optimization Tips

    • Peptide solubility issues: If incomplete dissolution occurs in water, switch to DMSO and ensure vigorous vortexing; avoid sonication to prevent peptide breakdown.
    • Batch-to-batch variability: Always purchase from a trusted supplier such as APExBIO and verify sequence fidelity with mass spectrometry if possible. Store aliquots at -20°C desiccated to maximize shelf-life.
    • Assay sensitivity: For cell-based readouts of leptin signaling, pre-validate receptor expression (Ob-R) and include positive controls with full-length leptin to benchmark activity. For in vivo studies, monitor food intake and energy expenditure using automated cages to capture subtle phenotypic changes.
    • Long-term solution stability: Use freshly prepared solutions; avoid storing reconstituted peptide beyond 24 hours, as recommended by the manufacturer.

    Why this Cross-Domain Matters, Maturity, and Limitations

    The intersection between inflammation, cardiac remodeling, and metabolic signaling is increasingly recognized as a research frontier. The findings from Zhou et al. demonstrate how modulating metabolic pathways (via SIRT6-AMPK) impacts both immune and cardiac endpoints, offering a mature, mechanistically integrated model for translational research. However, while the link between leptin signaling and SIRT6-AMPK is biologically plausible, direct evidence using Leptin (116-130), amide, mouse in cardiac or fibrosis models is still emerging. Caution is warranted in extrapolating from metabolic assays to organ-level outcomes without further validation, as noted in this thought-leadership review that frames current limitations and next steps for the field.

    Future Outlook: Integrating Mechanistic Insights for Next-Generation Research

    As protocols mature and cross-domain evidence accumulates, Leptin (116-130), amide, mouse is poised to become a cornerstone tool for dissecting the nexus of obesity, diabetes, and cardiovascular risk. Its role in precision modeling of energy homeostasis, coupled with the mechanistic clarity provided by studies like Zhou et al., positions it as a critical asset for both basic and translational researchers. Ongoing work will further clarify its utility in advanced disease models and refine dosing and assay strategies for maximal reproducibility. With rigorous supplier validation from APExBIO and a growing evidence base, this peptide fragment offers researchers unparalleled control and confidence in their metabolic and immunometabolic workflows.